Ownership Summary
Barinthus Biotherapeutics plc. (NASDAQ:BRNS) is held by 13 institutional investors per 13F filings through December 2025.
- Their combined ownership stood at 19.4% of outstanding shares in December 2025, down from 22.5% in September 2025.
- They increased total shares held in BRNS by 3.83% quarter over quarter, and investors in Barinthus Biotherapeutics decreased 23.53% from a year ago.
- Activity in BRNS broke down as 5 buyers, 2 sellers, and 6 unchanged among 13 total holders.
- Altogether, these fund groups held 7.9Mn shares in BRNS by December 2025, up by 291.83K shares quarter on quarter, and down 1.82Mn shares year over year.